(S)-3-[1-(Dimethylamino)ethyl]phenol CAS 139306-10-8 Rivastigmine Tartrate Intermediate Purity >99.0% (GC)
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of (S)-3-[1-(Dimethylamino)ethyl]phenol (CAS: 139306-10-8) with high quality, intermediate of Rivastigmine Tartrate (CAS: 129101-54-8). Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Purchase (S)-3-[1-(Dimethylamino)ethyl]phenol, Please contact: alvin@ruifuchem.com
Chemical Name | (S)-3-[1-(Dimethylamino)ethyl]phenol |
Synonyms | 3-[(1S)-1-(Dimethylamino)ethyl]phenol; NAP 226-90; Rivastigmine Metabolite; Rivastigmine Phenol Impurity |
Impurity | Rivastigmine EP Impurity A; Rivastigmin USP Related Compound C |
Stock Status | In Stock, Commercial Production |
CAS Number | 139306-10-8 |
Molecular Formula | C10H15NO |
Molecular Weight | 165.24 g/mol |
Melting Point | 117.0 to 121.0℃ |
Specific Rotation [a]20/D | -53.0° to -58.0° (C=1, MeOH) |
COA & MSDS | Available |
Origin | Shanghai, China |
Category | Intermediate of Rivastigmine Tartrate (CAS: 129101-54-8) |
Brand | Ruifu Chemical |
Items | Inspection Standards | Results |
Appearance | Off-White to Light Yellow Powder |
Complies |
Melting Point | 117.0 to 121.0℃ | Complies |
Purity / Analysis Method | >99.0% (GC) | 99.55% |
Isomer Assay | <0.50% | Complies |
Water by Karl Fischer | <0.50% | 0.23% |
Residue on Ignition | <0.20% | 0.09% |
Max. Single Impurity | <0.50% | Complies |
Total Impurities | <1.00% | 0.45% |
1H NMR Spectrum | Consistent with Structure | Complies |
Conclusion | The product has been tested and complies with the given specifications |
Package: Fluorinated Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry and well-ventilated warehouse away from incompatible substances. Protect from light and moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Risk Codes
R36 - Irritating to the eyes
R43 - May cause sensitization by skin contact
Safety Description
S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
HS Code 2922299090
(S)-3-[1-(Dimethylamino)ethyl]phenol (CAS: 139306-10-8), is a S-Enantiomer metabolite of Rivastigmine that is formed by hydrolysis. Intermediate / Impurity of Rivastigmine Tartrate (CAS: 129101-54-8). Rivastigmine (Exelon) is approved to prevent or slow the symptoms of mild to moderate AD or mild to moderate Parkinson's dementia. Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects,which typically include nausea and vomiting.The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions.